ImageneBio, Inc. (IMA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $94.53M | +680.1% |
| 2024 | $12.12M | -89.9% |
| 2023 | $119.89M | +100.1% |
| 2022 | $59.92M | -74.2% |
| 2021 | $232.22M | +42.9% |
| 2020 | $162.49M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $94.53M | +680.1% |
| 2024 | $12.12M | -89.9% |
| 2023 | $119.89M | +100.1% |
| 2022 | $59.92M | -74.2% |
| 2021 | $232.22M | +42.9% |
| 2020 | $162.49M | — |